drugset / Trial / NCT00745485

Feasibility of Doctors' Rooms-based Infusion of Zoledronic Acid

NCT00745485

Phase 4 Completed 186 enrolled Novartis Pharmaceuticals
RandomizedSingle-groupOpen-labelTreatment

Summary

1. The study will assess the safety and tolerability of a single-infusion of zoledronic acid 5 mg administered in a private medical practice setting by a nurse provided by a nationwide infusion service. Safety data will largely be monitored by investigating changes in the patients' well-being during the study. 2. The study will pilot and test a Patient Registry and Infusion Service process, which will allow zoledronic acid to be administered to trial patients in the investigators' private rooms by a team of roving nurses.

Timeline

Start
2008-08
Primary completion
2010-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified 5 mg

Indications